{"disease":{"id":"membranous-nephropathy-pla2r-induced","name":"membranous nephropathy pla2r induced"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05894512","title":"Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT05679336","title":"Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"St. Petersburg State Pavlov Medical University","has_results":false},{"nct_id":"NCT06285279","title":"The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Nanjing University School of Medicine","has_results":false},{"nct_id":"NCT07163611","title":"Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Radboud University Medical Center","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}